Frequently Asked Questions

WHAT SHOULD I EXPECT AFTER BOTOX®?

Botox® injections are a nonsurgical treatment to reduce the appearance of wrinkles and prevent the formation of new wrinkles and creases in both men and women. Botox® is injected in the targeted area with a very fine disposable needle. There is very little pain associated with the injections, usually described as a slight pinch. The results will begin in four to seven days, with the full benefits visible in two weeks. The results will last three to four months (some experience longer or shorter results), after which time patients will need a repeat treatment to maintain results.

ARE THERE ANY RESTRICTIONS AFTER BOTOX®?

Do not manipulate the treated area for 4 hours following treatment.

 

Do not receive facial/laser treatment or microdermabrasion after Botox® injections for at least 10 days.

 

Do not lie down for at least 4 hours following your Botox® treatment.

 

Do not perform vigorous activities involving straining, heavy lifting, or vigorous exercise for 12 hours after your Botox® treatment.

HOW SHOULD I PREPARE FOR BOTOX®?

We recommend avoiding alcohol for 24 hours before Botox®, as alcohol may thin your blood and increase the risk of bruising.​

Reschedule your appointment at least 24 hours in advance if you have a rash, cold sore, or infection in the area.

 

If you have an important event  (wedding, party, etc.) coming up, we recommend you schedule your appointment at least 3-4 weeks before the event so your Botox® will take full effect and there is adequate time to correct any potential side effects (i.e. bruising, asymmetry, etc.).

CAN I SEE BEFORE AND AFTER PHOTOS?

Please check out out social media to see the most up-to-date before and after photos and current specials.

Please see the Botox Treatment Areas page to see the different areas that we treat.

WHO CANNOT RECEIVE BOTOX®?

Individuals with known hypersensitivity to any botulinum toxin preparation (such as: Botox®, Myobloc®, Dysport®, or Xeomin®) or any of the components in the formulation. 

Individuals with known peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders.

 

Individuals with an active skin infection at the proposed injection site(s).

 

Individuals currently on aminoglycosides or other agents interfering with neuromuscular transmission.

Individuals currently pregnant or breastfeeding.